Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL IPSA Block vs LIA in Total Knee Arthroplasty
NCT07584915Phase 4Enrolling by invitation
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Numerical Rating Scale Pain Intensity Score. Started Jun 2026; status: enrolling by invitation.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07584915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07584915.